# IMCD completes acquisition of 70% stake in Signet Excipients Private Limited

IMCD N.V. has completed the acquisition of 70% of Indian speciality chemicals distributor Signet Excipients Private Limited, effective November 4, 2020. The remaining 30% shares will follow by 2024. Signet, based in Mumbai, generated revenue of INR 13.2 billion (ca. EUR 152 million) in the last twelve months.

- Type: Acquisition
- Announced: 2020-11-04
- Where: Mumbai, India
- Jobs: 100
- Status: completed
- Products: pharmaceutical, nutraceutical and bio-pharma excipients
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [IMCD](https://endata.com/companies/20622.md) (acquirer)
- [Signet Excipients Private Limited](https://endata.com/companies/49937.md) (target)

## Sources

- [nasdaq.com](https://www.nasdaq.com/press-release/imcd-completes-the-acquisition-of-signet-excipients-private-limited-2020-11-04), 2020-11-04: "The acquisition of Signet significantly strengthens IMCD’s presence in India and increases IMCD’s position in the high-growth APAC region."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.